Rozalina P.
- Country
- Bulgaria
- Department
- Department-Psychiatry Level II
Research Overview
- Pharmacokinetic Evaluation of LY03010 and Its Relative Bioavailability Compared to Paliperidone Palmitate in Schizophrenia Patients
- A Phase 2a Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GXV813 in Hospitalized Adults with Schizophrenia
- Evaluation of the Efficacy and Safety of Adjunctive Trospium Chloride and Xanomeline Tartrate in Patients with Inadequately Controlled Schizophrenia Symptoms
Data & Insights
Has run more than one trial at 39 of 78 partner sites.
Specializations
Psychiatric Disorders
Rozalina Petrova’s clinical research activity is strongly centered on schizophrenia and bipolar I disorder, with attention to acute symptom control, persistent behavioral and psychological symptoms, and longer-term treatment tolerability in adult patients.
- Schizophrenia
- Bipolar I disorder
- Mania and mania with mixed features
- Negative symptoms and behavioral symptoms
Her work in psychiatry reflects a sustained interest in therapeutic options for symptom reduction and maintenance care in severe mental illness.
Respiratory Medicine
Her trial portfolio includes treatment areas in asthma, chronic obstructive pulmonary disease, and chronic bronchitis, with a focus on control of exacerbations and management of persistent airway disease.
- Mild to moderate asthma
- Chronic obstructive pulmonary disease (COPD)
- Chronic bronchitis
- Seasonal allergic rhinitis and rhinoconjunctivitis
These studies place emphasis on chronic respiratory symptom burden and allergy-related airway disease.
Cardiometabolic and Vascular Disease
Rozalina Petrova is involved in clinical research addressing atherosclerotic cardiovascular disease, broader cardiovascular disease, and related metabolic conditions, including liver and heart-vessel disorders linked to cardiometabolic risk.
- Atherosclerotic cardiovascular disease
- Cardiovascular disease
- Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis
- Alcoholic liver disease and chronic viral hepatitis B
Her research landscape also includes therapies aimed at reducing vascular risk and supporting metabolic-liver health.
Renal, Hematologic, and Infectious Conditions
Her clinical interests extend to anemia in chronic kidney disease on dialysis, complicated urinary tract infection, acute pyelonephritis, and infectious disease settings such as COVID-19 and Clostridioides difficile infection.
- Chronic kidney disease and dialysis-related anemia
- Complicated urinary tract infection and acute pyelonephritis
- COVID-19
- Clostridioides difficile infection
This area also includes therapies relevant to hemostasis management and immune-mediated disease, such as primary Sjögren’s disease.
Neurologic, Pain, and Immune-Mediated Disease
Additional research involvement includes post-herpetic neuralgia and primary Sjögren’s disease, reflecting interest in pain syndromes and systemic autoimmune conditions.
- Post-herpetic neuralgia
- Primary Sjögren’s disease
- Systemic disease activity
- Autoimmune therapy
Her portfolio also touches on urgent perioperative anticoagulation reversal, linking acute care needs with therapeutic innovation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.